By Brian Kovalesky, StartUp Beat Editor
Today’s early-stage startup funding and acquisitions news:
Neurotrack, which has developed a diagnostic test for Alzheimer’s disease, has closed a $90,000 Seed funding round according to an SEC Form D filing. The funding was discovered and the news broken by VentureBeat, and investors have not yet been disclosed. The company offers a computer-based cognitive test that can detect an impaired Hippocampus—an early indicator of Alzheimer’s onset. Neurotrack licensed the technology, which was developed by U.C. San Diego and Emory University researchers. The startup first gained significant attention among the tech crowd when it won this year’s SXSW health prize. It is also a graduate of the Rock Health Boston accelerator and first launched at DEMO. The test is still in trial phase and is not yet available to the public.
More funding and acquisitions news…
Box acquires Folders and its ‘elegant’ French spin on file storage (via VentureBeat)
GiftCards.com Agrees To Buy Giftly To Grow A Mobile Platform (via TechCrunch)
Runscope raises $1.1m to help developers that rely on 3rd-party APIs (via The Next Web)
# # #